Literature DB >> 25527038

Neutrophil to lymphocyte ratio in Behçet's disease as a marker of disease activity.

Emine Nur Rifaioglu1, Bilge Bülbül Şen2, Özlem Ekiz2, Asena Cigdem Dogramaci2.   

Abstract

INTRODUCTION: Behçet's disease (BD) is a rare autoimmune disease. The neutrophil to lymphocyte ratio (NLR) is used as a marker of inflammation in several diseases nowadays. This study investigated the NLR as an inflammation marker in BD.
METHODS: Sixty-five patients diagnosed with BD and 100 healthy subjects were enrolled in this study retrospectively. The white blood cell (WBC), neutrophil, and lymphocyte counts were recorded, and the NLR was calculated from these parameters.
RESULTS: The NLR and the CRP and WBC levels were higher in patients with BD than controls (p < 0.001, p < 0.001, and p = 0.026, respectively). In addition, the NLR was higher in patients with active BD than in those with inactive BD (p = 0.033). DISCUSSION: The results demonstrate that the NLR is higher in patients with active BD compared to controls and those with inactive BD.

Entities:  

Mesh:

Year:  2014        PMID: 25527038

Source DB:  PubMed          Journal:  Acta Dermatovenerol Alp Pannonica Adriat        ISSN: 1318-4458


  17 in total

1.  Diagnostic Value of Neutrophil-Lymphocyte Ratios and Mean Platelet Volumes in the Activation of Recurrent Aphthous Stomatitis.

Authors:  Sinan Uluyol; Saffet Kilicaslan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-01-12

2.  Neutrophil to lymphocyte ratio may be a helpful marker to evaluate disease activity in NMOSD.

Authors:  Jie Lin; Binbin Xue; Jia Li; Huaqing Xu; Xiaming Huang; Zhichao Yao; Xiang Li; Junhui Xia
Journal:  Neurol Sci       Date:  2017-08-04       Impact factor: 3.307

3.  Predictive contribution of neutrophil/lymphocyte ratio in diagnosis of brucellosis.

Authors:  Serdar Olt; Hasan Ergenç; Seyyid Bilal Açıkgöz
Journal:  Biomed Res Int       Date:  2015-02-03       Impact factor: 3.411

4.  Neutrophil/lymphocyte ratio in obese adolescents.

Authors:  Murat Aydin; Ahsen Yilmaz; Mustafa Metin Donma; Feti Tulubas; Muhammed Demirkol; Murat Erdogan; Ahmet Gurel
Journal:  North Clin Istanb       Date:  2015-09-25

5.  Baseline peripheral blood neutrophil-to-lymphocyte ratio could predict survival in patients with adult polymyositis and dermatomyositis: A retrospective observational study.

Authors:  You-Jung Ha; Jaehyung Hur; Dong Jin Go; Eun Ha Kang; Jin Kyun Park; Eun Young Lee; Kichul Shin; Eun Bong Lee; Yeong Wook Song; Yun Jong Lee
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

6.  The prognostic value of the neutrophil/lymphocyte ratio in patients with snake bites for clinical outcomes and complications.

Authors:  Bilal Elbey; Burhan Baykal; Ümit Can Yazgan; Yılmaz Zengin
Journal:  Saudi J Biol Sci       Date:  2015-10-19       Impact factor: 4.219

7.  Neutrophil/Lymphocyte Ratio, Serum Endocan, and Nesfatin-1 Levels in Patients with Psoriasis Vulgaris Undergoing Phototherapy Treatment.

Authors:  Aybala Erek Toprak; Emin Ozlu; Tugba Kevser Uzuncakmak; Emre Yalcınkaya; Sadık Sogut; Ayşe Serap Karadag
Journal:  Med Sci Monit       Date:  2016-04-12

8.  Hematological Indices May Be Useful in the Diagnosis of Systemic Lupus Erythematosus and in Determining Disease Activity in Behçet's Disease.

Authors:  Servet Yolbas; Ahmet Yildirim; Nevzat Gozel; Burak Uz; Suleyman Serdar Koca
Journal:  Med Princ Pract       Date:  2016-06-24       Impact factor: 1.927

9.  Can we use the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume values for the diagnosis of anterior uveitis in patients with Behcet's disease?

Authors:  Atil Avci; Deniz Avci; Fatma Erden; Ertas Ragip; Ali Cetinkaya; Kemal Ozyurt; Mustafa Atasoy
Journal:  Ther Clin Risk Manag       Date:  2017-07-17       Impact factor: 2.423

10.  Neutrophil to Lymphocyte Ratio and Mean Platelet Volume as Inflammatory Indicators in Systemic Lupus Erythematosus Nephritis.

Authors:  Ata Bora Ayna; Selime Ermurat; Belkis Nihan Coşkun; Halil Harman; Yavuz Pehlivan
Journal:  Arch Rheumatol       Date:  2016-08-17       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.